Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone's effects on COVID-19 are unclear and need more research.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Millets may help reduce chemotherapy side effects like nausea, fatigue, and hair loss.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Genes related to calcium signaling and lipid metabolism are important for curly hair in Mangalitza pigs.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Adipokines affect skin health and could be targeted for treating skin diseases.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

The 2012 criteria are better for diagnosing atypical lupus cases.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Removing Mediator 1 from certain mouse cells causes teeth to grow hair instead of enamel.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Genomic approach finds new possible treatments for hair loss.